DJO Global announced FDA 510(k) clearance for the Exprt® Revision Hip, to be priced up to 70% lower than comparable revision hip devices.
The full-line modular femoral stem was inspired by the clinical success of Wagner-style implants, and offers an anatomical design. Further, the two-tray system represents an 80% to 90% reduction in instruments vs. competitive systems.
The company's Exprt™ Precision revision knee launched in 2015.
DJO Global is offering a preview of the Exprt Revision Hip at the 2017 AAOS meeting in Booth #1733.
Sources: DJO Global; ORTHOWORLD Inc.